Pre-Open Stock Movers 07/31: (PINS) (FB) (AAPL) (AMZN) Higher; (TEAM) (MOH) (RDFN) Lower (more...)

July 31, 2020 9:23 AM

Pre-Open Stock Movers

electroCore, Inc. (Nasdaq: ECOR) 81.8% HIGHER; announced more information about availability, distribution and pricing for gammaCore Sapphire CV non-invasive vagus nerve stimulation (nVNS) therapy under its Emergency Use Authorization (EUA). The EUA allows for the use of gammaCore Sapphire CV at home or in a healthcare setting to acutely treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.

Tiziana Life Sciences plc (Nasdaq: TLSA) 37.4% HIGHER; announce that it has submitted a patent application for the potential use of nasally administered Foralumab, a fully human anti-CD3 monoclonal antibody (mAb), for the treatment of COVID-19 either alone or in combination with other anti-viral drugs. Recent clinical studies imply that a combination of anti-inflammatory and anti-viral drugs may be more effective to treat patients at different stages of COVID-19 disease.

Pinterest (NYSE: PINS) 36.4% HIGHER; reported Q2 EPS of ($0.07), $0.06 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $272 million versus the consensus estimate of $251.24 million.
Sesen Bio (NASDAQ: SESN) 18.9% HIGHER; today announced that the companies have entered into an exclusive licensing agreement for the manufacture, development and commercialization of Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer and other types of cancer in China, Hong Kong, Macau and Taiwan.
Sorrento Therapeutics (NASDAQ: SRNE) 13.5% HIGHER; H.C. Wainwright raised the price target on to $30.00 (from $24.00) while maintaining a Buy rating.

Northern Oil and Gas, Inc. (NYSE: NOG) 13.3% HIGHER; announced that it has entered into definitive agreements to acquire producing properties, wells in process and acreage in the core of the Williston Basin from multiple counterparties (the Sellers). In addition, the Company has entered into exchange agreements with holders of its Senior Notes due 2023 and its Series A Preferred Stock.

Under Armour Inc (NYSE: UAA) (NYSE: UA) 12% HIGHER; reported Q2 EPS of ($0.31), $0.10 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $708 million versus the consensus estimate of $543.8 million.

Durect Corp (NASDAQ: DRRX) 11.9% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $7.00.

CymaBay Therapeutic (NASDAQ: CBAY) 9.7% HIGHER; Piper Sandler initiates coverage with an Overweight rating and a price target of $12.00.

Altimmune (NASDAQ: ALT) 8.2% HIGHER; Piper Sandler initiates coverage with an Overweight rating and a price target of $80.00.

Atlassian (NASDAQ: TEAM) 8% LOWER; reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $430.5 million versus the consensus estimate of $410.71 million. Atlassian sees Q1 2021 EPS of $0.26-$0.27, versus the consensus of $0.29. Atlassian sees Q1 2021 revenue of $430-445 million, versus the consensus of $438.88 million.

Molina Healthcare (NYSE: MOH) 7.5% LOWER; reported Q2 EPS of $4.79, $0.06 better than the analyst estimate of $4.73. Revenue for the quarter came in at $4.37 billion versus the consensus estimate of $4.72 billion. Molina Healthcare sees FY2020 EPS of $11.20-$11.70, versus the consensus of $11.94. Molina Healthcare sees FY2020 revenues of $21.5 billion, versus the consensus of $18.96 billions.

Beazer Homes (NYSE: BZH) 7.2% HIGHER; reported Q3 EPS of $0.51, $0.60 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $532.5 million versus the consensus estimate of $427.4 million.

Redfin (NASDAQ: RDFN) 7% LOWER; reported Q2 EPS of ($0.08), $0.15 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $214 million versus the consensus estimate of $189.1 million. Redfin sees Q3 2020 revenue of $214-225 million, versus the consensus of $221.4 million.

Facebook (NASDAQ: FB) 6.6% HIGHER; reported Q2 EPS of $1.80, $0.41 better than the analyst estimate of $1.39. Revenue for the quarter came in at $18.69 billion versus the consensus estimate of $17.4 billion.

Emergent BioSolutions (NYSE: EBS) 6.2% HIGHER; reported Q2 EPS of $1.98, $1.30 better than the analyst estimate of $0.68. Revenue for the quarter came in at $394.7 million versus the consensus estimate of $294.73 million. Emergent BioSolutions sees Q3 2020 revenue of $420-450 million, versus the consensus of $420.2 million. Emergent BioSolutions sees FY2020 revenue of $1.5-1.6 billion, versus the consensus of $1.39 billion.

Apple (NASDAQ: AAPL) 6% HIGHER; reported Q3 EPS of $2.58, $0.54 better than the analyst estimate of $2.04. Revenue for the quarter came in at $59.7 billion versus the consensus estimate of $52.25 billion. The Board of Directors has also approved a four-for-one stock split to make the stock more accessible to a broader base of investors.

World Wrestling Entertainment (NYSE: WWE) 5.9% HIGHER; reported Q2 EPS of $0.52, $0.38 better than the analyst estimate of $0.14. Revenue for the quarter came in at $223.4 million versus the consensus estimate of $228.4 million.

Bandwidth, Inc. (NASDAQ: BAND) 5.7% HIGHER; reported Q2 EPS of $0.13, $0.13 better than the analyst estimate of $0.00. Revenue for the quarter came in at $76.8 million versus the consensus estimate of $70.51 million.Bandwidth, Inc. sees Q3 2020 EPS of ($0.03)-($0.01), versus the consensus of ($0.02). Bandwidth, Inc. sees Q3 2020 revenue of $76-76.5 million, versus the consensus of $71.1 million. Bandwidth, Inc. sees FY2020 EPS of $0.05-$0.11, versus the consensus of $0.02. Bandwidth, Inc. sees FY2020 revenue of $296.8-298.3 million, versus the consensus of $282.3 million.

Amazon (NASDAQ: AMZN) 5% HIGHER; reported Q2 EPS of $10.30, $8.84 better than the analyst estimate of $1.46. Revenue for the quarter came in at $88.9 billion versus the consensus estimate of $81.53 billion. Amazon sees Q3 2020 revenue of $87-93 billion, versus the consensus of $86.3 billion.

Allscripts (NASDAQ: MDRX) 5% HIGHER; reported Q2 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $406.2 million versus the consensus estimate of $398.96 million. Signed definitive agreement to sell EPSi business unit for $365 million

Shake Shack (NYSE: SHAK) 4.6% LOWER; reported Q2 EPS of ($0.45), $0.08 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $91.8 million versus the consensus estimate of $93.01 million. Same-Shack sales decreased 49.0%.

2u (NASDAQ: TWOU) 4.3% LOWER; reported Q2 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $182.7 million versus the consensus estimate of $174.56 million.

Chevron (NYSE: CVX) 4% LOWER; reported Q2 EPS of ($1.59), $0.67 worse than the analyst estimate of ($0.92). Revenue for the quarter came in at $16 billion versus the consensus estimate of $22.1 billion.

Expedia (NASDAQ: EXPE) 3.5% LOWER; reported Q2 EPS of ($4.09), $0.75 worse than the analyst estimate of ($3.34). Revenue for the quarter came in at $566 million versus the consensus estimate of $675.33 million.

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) 0.8% HIGHER; reported Q2 EPS of $10.13, $1.92 better than the analyst estimate of $8.21. Revenue for the quarter came in at $38.3 billion versus the consensus estimate of $37.37 billion.

Categories

Special Reports

Next Articles